-
Company Profile
LadRx Corp – Company Profile
LadRx Corp (LadRx ) formerly CytRx, is a biopharmaceutical company that focuses on the discovery and development of new therapeutics for the treatment of cancer and neurodegenerative diseases. LadRx’s product candidate, aldoxorubicin, is in the late stage of clinical development, and finds application in treating relapsed soft tissue melanoma, small-cell lung cancer, and other types of cancer with unmet medical needs. The company also has other pipeline products being developed through linker activated drug release technology platform. It has milestone...
Add to Basket -
Product Insights
Human Immunodeficiency Virus (HIV) Infections (AIDS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Human Immunodeficiency Virus Pipeline market research report provides a comprehensive overview on the therapeutics under development for Human Immunodeficiency Virus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Human Immunodeficiency...
-
Product Insights
Chondrosarcoma Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H1, 2017" provides an overview of Chondrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Chondrosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Chondrosarcoma Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H2, 2018" provides an overview of Chondrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Chondrosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Acute Promyelocytic Leukemia Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Acute Promyelocytic Leukemia Global Clinical Trials Review, H2, 2018" provides an overview of Acute Promyelocytic Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Promyelocytic Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2017" provides an overview of Acute Promyelocytic Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Promyelocytic Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Pancreatic Cancer Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Acute Promyelocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of Acute Promyelocytic Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Promyelocytic Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...